申请人:Hoechst Aktiengesellschaft
公开号:US04285946A1
公开(公告)日:1981-08-25
What is disclosed are 4-amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides of the formula ##STR1## further defined in the specification, and physiologically acceptable acid addition salts thereof, methods for treating adiposity and disturbances of the lipometabolism with these compounds or salts, and pharmaceutical compositions containing these compounds or salts and useful for inducing anorexia or affecting the lipometabolism.
所披露的是公式##STR1##的4-氨基-2-脲(或-硫脲)-嘧啶-5-羧酸苯胺衍生物及其生理学上可接受的酸加合物,使用这些化合物或盐治疗肥胖和脂质代谢紊乱的方法,以及含有这些化合物或盐的药物组合物,用于诱导厌食或影响脂质代谢。